Tech Company Financing Transactions

NxThera Funding Round

NxThera secured a $40 million funding round on 12/4/2015. Investors included Boston Scientific Corporation, Aberdare Ventures and Ally Bridge Group.

Transaction Overview

Company Name
NxThera
Announced On
12/4/2015
Transaction Type
Debt
Venture Equity
Amount
$40,000,000
Round
Undisclosed
Investors

Boston Scientific Corporation (Lead Investor)

Aberdare Ventures (Sigrid Van Bladel)

Ally Bridge Group

Arboretum Ventures (Jan Garfinkle)

East West Bank

GDN Holdings (Glen Nelson)

Proceeds Purpose
The Company intends to use the proceeds from this round to expand sales of the Rezum System to treat benign prostate hyperplasia (BPH) in the U.S. and selected international markets. The Rezum System received FDA clearance in August and allows urologists to treat their BPH patients in a variety of clinical settings, including in urology clinics as well as surgical centers.

Company Information

Company Status
Acquired or Merged
Industry
Medical Devices & Instruments
Mailing Address
7351 Kirkwood Lane N 138
Maple Grove, MN 55369
USA
Phone
(763) 515-0404
Website
www.nxthera.com
Email Address
[email protected]
Overview
NxThera develops medical technologies to treat a variety of endourology conditions, including BPH. The company's technology platform utilizes a simple, minimally invasive, vapor therapy designed to measurably improve urinary flow and patient quality of life.
Profile
NxThera LinkedIn Company Profile
Social Media
NxThera Company Twitter Account
Company News
NxThera News
Facebook
NxThera on Facebook
YouTube
NxThera on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Robert Paulson
  Robert Paulson LinkedIn Profile  Robert Paulson Twitter Account  Robert Paulson News  Robert Paulson on Facebook
Chief Financial Officer
Carmen Bringgold
  Carmen Bringgold LinkedIn Profile  Carmen Bringgold Twitter Account  Carmen Bringgold News  Carmen Bringgold on Facebook
Chief Marketing Officer
Michael Kujak
  Michael Kujak LinkedIn Profile  Michael Kujak Twitter Account  Michael Kujak News  Michael Kujak on Facebook
Chief Operating Officer
Maximillian Fiore
  Maximillian Fiore LinkedIn Profile  Maximillian Fiore Twitter Account  Maximillian Fiore News  Maximillian Fiore on Facebook
Chief Technical Officer
Michael Hoey
  Michael Hoey LinkedIn Profile  Michael Hoey Twitter Account  Michael Hoey News  Michael Hoey on Facebook
VP - Engineering
Tim Byland
  Tim Byland LinkedIn Profile  Tim Byland Twitter Account  Tim Byland News  Tim Byland on Facebook
VP - Product Management
Mona Dahdah
  Mona Dahdah LinkedIn Profile  Mona Dahdah Twitter Account  Mona Dahdah News  Mona Dahdah on Facebook

 

 

Browse more venture capital transactions:

Prev: 12/4/2015: 3PL Central venture capital transaction
Next: 12/4/2015: ZeroFOX venture capital transaction

 

Share this article

 

Where The Data Comes From

Our team works diligently to document all VC transactions involving tech companies. VC transactions reported here come from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.